Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Prostaglandins & Other Lipid Mediators|July 20, 2019
Liquid chromatography-coupled mass spectrometry analysis of glutathione conjugates of oxygenated polyunsaturated fatty acidsStefanie Liening, Erik Romp, Oliver Werz, et al.
FEBS Letters|May 9, 2025
Modifications in FLAP's second cytosolic loop influence 5-LOX interaction, inhibitor binding, and leukotriene formationErik Romp, Katharina Rataj, Stefanie König, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2016
5-Lipoxygenase-activating protein rescues activity of 5-lipoxygenase mutations that delay nuclear membrane association and disrupt product formationJana Gerstmeier, Marcia E Newcomer, Sophie Dennhardt, et al.
Cellular and Molecular Life Sciences : CMLS|December 7, 2019
Exotoxins from Staphylococcus aureus activate 5-lipoxygenase and induce leukotriene biosynthesisErik Romp, Vandana Arakandy, Jana Fischer, et al.
Scientific Reports|February 21, 2017
Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screeningVeronika Temml, Ulrike Garscha, Erik Romp, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 20, 2022
Synthesis and structure-activity relationships for some novel diflapolin derivatives with benzimidazole subunitLisa Vieider, Eva Zoeller, Erik Romp, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Synthesis, Biological Evaluation and Structure-Activity Relationships of Diflapolin Analogues as Dual sEH/FLAP InhibitorsLisa Vieider, Erik Romp, Veronika Temml, et al.
Cell Chemical Biology|November 13, 2018
Melleolides from Honey Mushroom Inhibit 5-Lipoxygenase via Cys159Stefanie König, Erik Romp, Verena Krauth, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 9, 2019
Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolomeMarkus Werner, Paul M Jordan, Erik Romp, et al.
Scientific Reports|August 26, 2017
Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolaseUlrike Garscha, Erik Romp, Simona Pace, et al.
Pageof 2